Glaxo begins battle for cervical cancer market
CATHERINE BOYLE
The Business
10 Mar 2007
GLAXOSMITHKLINE (GSK), the drugs giant, is to apply for American approval of its cervical cancer vaccine within weeks. Its Cervarix injection would compete head-on with Gardasil, the vaccine developed by Merck in partnership with Sanofi Aventis, which... read more...
posted by Bank Report at
9:48 PM
0 Comments:
Post a Comment
<< Home